Arthur P. Pasquarella of Gwynedd Valley, Pennsylvania was elected chairman of the National Kidney Foundation, during the organization’s Oct. 3rd board of directors’ meeting. Pasquarella is Chief Operating Officer of Equus Capital Partners Ltd., a nationwide real estate investment company based in the Philadelphia area. He holds an MS in Real Estate Appraisal and Investment Analysis from the University of Wisconsin-Madison and a BS in Finance from Pennsylvania State University. He is a member of the Counselors of Real Estate and served as the 2010 Chair of its national board of directors.
Pasquarella has a long family history of kidney disease. His father, Valentino H. Pasquarella, Sr., received a kidney transplant in the mid-1990s and Art donated a kidney to his brother, Val, Jr., in 2010.
“Having witnessed firsthand both the significant challenges that kidney disease presented to my loved ones, as well as the life-changing value of kidney donation, I am determined to help reduce the incidence of kidney disease and increase transplantation rates in the U.S.,” said Pasquarella.
Art has been actively involved with the National Kidney Foundation since 2006 when he joined the Delaware Valley Board. In 2011, he joined the National Board as well. He previously served as the 2010-2012 Chair of the Foundation’s Delaware Valley Board and as the Development Committee Chair for the National Board. He is also a former Chair of the Board of Directors of Mount Saint Joseph Academy in Flourtown, Pennsylvania.
Pasquarella said his priorities include advancing the foundation’s new CKD Intercept initiative to provide primary care clinicians with the essential skills and tools to recognize, diagnose and treat early stage kidney disease. This includes helping clinicians to better support patients in managing conditions that contribute to kidney disease, such as diabetes, high blood pressure and heart disease. This groundbreaking program will develop innovative professional education activities to expedite change in primary care.
“Art has long been dedicated to the fight against kidney disease. He has proven his commitment to the kidney cause, serving on NKF Boards at both the national and local levels for many years,” said Kevin Longino, National Kidney Foundation CEO. “His professional success, coupled with his personal connection with kidney disease and organ donation, will be a powerful asset as NKF advances our mission to increase testing for those at risk, further professional education about kidney disease and reduce the waiting period to receive a kidney for transplant.”